Reviva Pharmaceuticals Warrants
RVPHW
RVPHW was delisted on the 12th of December, 2025.
4 hedge funds and large institutions have $240K invested in Reviva Pharmaceuticals Warrants in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.02% less ownership
Funds ownership: 0.71% → 0.69% (-0.02%)
6% less capital invested
Capital invested by funds: $255K → $240K (-$15.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$14.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
NewSquare Capital
Newtown Square,
Pennsylvania
|
-$886 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
Arena Investors
Purchase,
New York
| $131K | – | – | – |
|
2
Walleye Capital
New York
| $51.9K | – | – | – |
|
3
Walleye Trading
New York
| $39.6K | – | – | – |
|
|
BRWA
4
B. Riley Wealth Advisors
Boca Raton,
Florida
| $17.1K | +$14.4K | +11,101 | New |
|
|
NC
5
NewSquare Capital
Newtown Square,
Pennsylvania
| – | -$886 | -500 | Closed |
|
RVPHW Hedge Fund Activity: Q3 2023 in Review
4 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q3 2023, worth a combined $240K — down 6% from $255K a quarter earlier.
Fund positioning in RVPHW was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was B. Riley Wealth Advisors, opening a new position worth an estimated $14.4K. The largest seller was NewSquare Capital, exiting entirely with an estimated $886 sold.
- 4 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $240K of Reviva Pharmaceuticals Warrants stock for Q3 2023, down 6% quarter-over-quarter.
- 1 fund opened new Reviva Pharmaceuticals Warrants positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest Reviva Pharmaceuticals Warrants buyer in Q3 2023 was B. Riley Wealth Advisors, an estimated $14.4K added.
- The largest Reviva Pharmaceuticals Warrants seller in Q3 2023 was NewSquare Capital, an estimated $886 sold.
Based on aggregated 13F filings for Q3 2023.